Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 9 April 2025 - 16:01

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ronapreve

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters